Cargando…
Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
SIMPLE SUMMARY: Immunotherapy agents, such as immune checkpoint inhibitors (ICIs), act through different mechanisms compared to conventional chemotherapy and are characterized by unique patterns of response, such as hyperprogression (HPD), which refers to the paradoxical acceleration of tumor growth...
Autores principales: | Economopoulou, Panagiota, Anastasiou, Maria, Papaxoinis, George, Spathas, Nikolaos, Spathis, Aris, Oikonomopoulos, Nikolaos, Kotsantis, Ioannis, Tsavaris, Onoufrios, Gkotzamanidou, Maria, Gavrielatou, Niki, Vagia, Elena, Kyrodimos, Efthymios, Gagari, Eleni, Giotakis, Evangelos, Delides, Alexander, Psyrri, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828787/ https://www.ncbi.nlm.nih.gov/pubmed/33466719 http://dx.doi.org/10.3390/cancers13020286 |
Ejemplares similares
-
Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature
por: Tsavaris, Onoufrios, et al.
Publicado: (2018) -
Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2020) -
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
por: Moutafi, Myrto, et al.
Publicado: (2023) -
Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021) -
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
por: Psyrri, A., et al.
Publicado: (2021)